Danice E.C. Wilkins is the Scientific Director for Immunology and Biomarkers at our Shrewsbury, MA site. She previously worked with Charles River Nevada as the Program Director for Immunology and the Lead Scientist for flow cytometry and pharmacodynamic assays. Dr. Wilkins has also held leadership positions at Momenta Pharmaceuticals and Elstar Therapeutics. She has experience in the strategic design and outsourcing of preclinical in vivo pharmacodynamic and immunotoxicology studies, as well as the development and validation of flow cytometry and cell-based functional bioassays and immunology biomarkers.
Dr. Wilkins earned her MS and PhD in cellular and molecular biology from the University of Nevada School of Medicine in Reno, where her projects focused on the effects of agonist anti-CD40 antibodies on renal cell carcinomas and antigen-independent T cell responses to cancer immunotherapy.